The Insights Association helped Arkansas, Oklahoma, and Tennessee approve changes this year harmonizing their treatment of independent contractors, including respondents who receive incentives for their participation in research studies.
Each time the state of Minnesota has tried to clarify treatment of respondent incentives for the participation of health care practitioners in marketing research sponsored by pharmaceutical manufacturers, companies still end up confused. What do the law, regulations and guidance tell us?
Philadelphia Rejects Bill That Would Have Banned Pharmaceutical Marketing Research with Healthcare Professionals
Legislation in the city of Philadelphia that would have cut off pharmaceutical marketing research with doctors was defeated in the city council yesterday.
The Insights Association contributes to Pharma Market Research Report 14th Annual Predictions Issue
The Insights Association today joined a coalition letter with 21 other organizations sent to relevant leaders on the House Education & Workforce Committee, urging their prompt approval of the
New regulations in New Jersey restricting interactions between medical professionals and pharmaceutical manufacturers should not impede marketing research, thanks to the advocacy of the Insights As
MM&M magazine interviews the Insights Association while examining the growing regulation of pharmaceutical marketing research
The Insights Association testified in New Jersey about proposed regulations on payments to medical professionals, urging an exemption for pharmaceutical marketing research incentive payments.
Carlos Garcia explains how pharmaceutical marketing research helped combat diabetes in the Latino community